NCT02870218View on ClinicalTrials.gov

Abuse Liability of Reduced Nicotine Content Cigarettes in the Context of Concurrent E-Cigarette Use

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

July 28, 2021

Study Completion Date

July 28, 2021

Conditions
Nicotine AddictionCigarette Smoking
Interventions
DRUG

Smoking research cigarettes with e-cigarette

Smoking research cigarettes with varying levels of nicotine with unlimited access to 15 mg/ml nicotine-containing e-cigarettes.

DRUG

Nicotine discrimination thresholds

Measure of nicotine thresholds for detecting and recognizing the addictive, rewarding effects of smoking.

Trial Locations (2)

27617

Rose Research Center, Raleigh

28262

Rose Research Center, Charlotte

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

Food and Drug Administration (FDA)

FED

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Rose Research Center, LLC

INDUSTRY

NCT02870218 - Abuse Liability of Reduced Nicotine Content Cigarettes in the Context of Concurrent E-Cigarette Use | Biotech Hunter | Biotech Hunter